Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Udmurtneft approved dividends for 2023

7/1/24 UDMN

Shareholders of Novorossiysk Bakery Products Plant approved dividends for 2023

7/1/24 NKHP

Lenta brought fresh to Ozon

7/1/24 LENT

Alrosa acquired a gold deposit

7/1/24 ALRS

Shareholders of Astra approved dividends for 3 months 2024

7/1/24 ASTR

SberMarket became Cooper

7/1/24 SBER

Samolet Plus will hold pre-IPO in the first half of July

7/1/24 SMLT

Samolet Plus will hold pre-IPO in the first half of July

7/1/24 OTCI

Consortium.First announced the results of the exchange of Yandex N.V. shares

7/1/24 YNDX

Consortium.First announced the results of the exchange of Yandex N.V. shares

7/1/24 YDEX